CDER Compliance Office Redesign Includes Internet, Risk Management Focus
This article was originally published in The Tan Sheet
Executive Summary
The FDA Center for Drug Evaluation & Research's reorganized Office of Compliance includes a team focused on illegal sale of OTC and prescription drugs on the Internet
You may also be interested in...
Office of Compliance (correction)
John Loh continues as the New Drugs & Labeling Team Leader in the Center for Drug Evaluation & Research's reorganized Office of Compliance. "The Pink Sheet" (1Feb. 3, p. 33) incorrectly reported Loh as leader of the imports and exports team, which is currently vacant...
Office of Compliance (correction)
John Loh continues as the New Drugs & Labeling Team Leader in the Center for Drug Evaluation & Research's reorganized Office of Compliance. "The Pink Sheet" (1Feb. 3, p. 33) incorrectly reported Loh as leader of the imports and exports team, which is currently vacant...
FDA Internet Enforcement Without Guidance May Create "Incongruity" - Lilly
FDA's decision to halt work on an Internet guidance could result in enforcement "incongruity," Lilly Associate Internet Consultant Michael Pozsgai told a Drug Information Association conference in Washington D.C. Nov. 3.